Le Lézard
Classified in: Health
Subjects: NPT, CHI, LEG, AVO

Family Research Council Urges Ohio Legislature to Override Ohio Governor's Veto of the SAFE Act


WASHINGTON, Dec. 29, 2023 /PRNewswire/ -- Earlier today, Ohio Governor Mike DeWine announced his decision to veto House Bill 68, also referred to as the Saving Adolescents from Experimentation (SAFE) Act. If enacted, the bill will protect Ohio minors from gender-transition procedures (including chemical procedures, surgical procedures, and psychological inducement) or from being diagnosed or subjected to gender transition counseling without the consent of at least one parent, legal custodian, or guardian. It also protects parents from losing custody over this issue--a known problem in Ohio since at least 2018.

Ohio Lt. Gov. Jon Husted yesterday voiced support for HB 68.

 Family Research Council President Tony Perkins released the following statement in response:

"Governor Mike DeWine's veto of the SAFE Act will have devastating consequences for Ohio's children, unless the legislature moves to override. Minors cannot drive cars, purchase cigarettes, or consume alcohol legally. Parents cannot take newborn infants home from the hospital without a car seat or allow children to ride in an automobile without a seatbelt. Yet, in the absence of this legislation, there is a green light to alter, and even do irreversible harm, to children's bodies. This is medical experimentation on minors, pure and simple.

"The harmful gender ideology sweeping across our nation creates a growing and urgent need for legislative protection of children vulnerable to life-altering procedures such as puberty-blocking drugs, cross-sex hormones, and irreversible surgeries. Research has not shown that these procedures are effective in improving a patient's mental health. They have serious negative side effects, up to and including permanent sterilization--thus violating the most fundamental principle of medical ethics, 'First, do no harm.'  

"A growing number of individuals are coming forward to share their stories about being permanently maimed, highlighting the need for legal remedies. The SAFE Act addresses this critical need while also ensuring that the government never uses taxpayer dollars to pay for experiments that will damage the lives of the next generation.

"This is a sad day for Ohio. However, Lieutenant Governor Jon Husted should be applauded for his decision to stand in support of Ohio's SAFE Act.

"Family Research Council urges Ohio legislators to override Governor DeWine's veto and pass the SAFE Act into law to protect vulnerable children from experimental procedures that cause physiological trauma for those dealing with gender dysphoria. There is no 'right' to inflict dangerous, and often irreversible, procedures on minors, and it is fully within the legitimate power of each state to regulate such practices."

Walt Heyer, a Senior Fellow with FRC, also commented:

"I detransitioned over 30 years ago. I know about consequences. The known consequences of these experimental procedures include infertility, sterility, osteoporosis, liver damage, mental health issues, including suicide ideation, and skeletal bone thinning. Years from now, today's children who are so convinced they need these experimental procedures will be confronted by the tragic personal consequences arising from Governor DeWine's veto."

CONTACT: J.P. Duffy or Alice Chao, (866) FRC-NEWS or (866)-372-6397

SOURCE Family Research Council


These press releases may also interest you

at 07:05
BeiGene, Ltd. , a global oncology company, today announced the appointment of Matt Shaulis as General Manager of North America, effective September 25. "We are excited to welcome Matt, who brings a wealth of global pharmaceutical experience,...

at 07:05
LuminUltra (luminultra.com), the global leader in applied molecular diagnostics, today announced the acquisition of the legionella testing business assets of Genomadix Inc (genomadix.com), along with rights to develop and commercialize further assays...

at 07:05
Novocure announced today it will present a real-world analysis of usage of its Tumor Treating Fields (TTFields) therapy and survival outcomes in newly diagnosed glioblastoma (ndGBM) patients at the European Society for Medical Oncology (ESMO)...

at 07:05
Enigma Biomedical USA (EB) today announced a collaboration with Alamar Biosciences in the field of neurology. Through this collaboration, EB has a non-exclusive right to introduce Alamar's protein detection and measurement technologies, including its...

at 07:05
HC Bioscience, a pioneering biopharmaceutical company developing a novel approach to treating genetically defined diseases through tRNA-based protein editing, today announces the appointment of Simon Tsang, Ph.D. as its Chief Business Officer (CBO)....

at 07:05
Mispro, a leading contract vivarium organization (CVO), has announced that its newest Metro-Boston facility will open this December on Binney Street in Kendall Square, Cambridge, MA. Strategically positioned in the heart of Kendall Square, a...



News published on and distributed by: